Setback: DCGI rejects Dr Reddys Application For Full Marketing Of Remdesivir Ruchika Sharma3 Nov 2020 1:45 PM IST"After detailed deliberation, the committee did not recommend for grant of full marketing authorization to Dr Reddy's Labs and opined that approval...
Approval of FDCs: NPPA flags prospects of over medication, profiteering Farhat Nasim2 Nov 2020 3:46 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has recently expressed its concern over approving Fixed Dose Combinations (FDCs) of...
Sanofi, Regeneron win EU patent case against Amgen over Praluent Ruchika Sharma1 Nov 2020 11:15 AM IST"We are pleased with today's decision by the European Patent Office, which upholds the rigorous standard for pharmaceutical patents that we argued for...
Govt to bring Tapentadol under Schedule H1 to curb its misuse Farhat Nasim31 Oct 2020 7:07 PM ISTNew Delhi: Through a recent Gazette Notification, the Union Ministry of Health and Family Welfare(MoHFW) has notified a draft amendment to the Drugs...
Use of Remdesivir, Favipiravir drugs to treat COVID- 19: SC Asks Centre to clarify stand Ruchika Sharma30 Oct 2020 12:00 PM ISTRemdesivir and Favipiravir are antiviral drugs and their efficacy in treating Covid-19 patients has been a matter of debate among medical experts.
Medtronic, Apollo Hospitals ink pact to integrate AI for stroke management in India Farhat Nasim29 Oct 2020 4:58 PM ISTThrough this partnership, Medtronic will help in bringing in stroke technologies, technical expertise, training, and comprehensive stroke management...
Panel asks CDSCO to scrutinize report on adverse reaction of HCQ Farhat Nasim28 Oct 2020 5:52 PM ISTNew Delhi: Popular antimalarial drug Hydroxychloroquine (HCQ) has come under intense scrutiny over reports of adverse reaction of the drug,...
CDSCO panel rejects GSK Phase IV trial protocol of combination drug indicated for Acute Otitis Media Farhat Nasim27 Oct 2020 3:39 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) has recently declined a...
SEBI imposes fine on Biocon's regulatory affair officer for insider trading Ruchika Sharma26 Oct 2020 3:18 PM ISTMumbai: In a major setback to Biocon Ltd., markets regulator Securities and Exchange Board of India (SEBI)on Friday levied a fine on an employee...
Nations mulling Gilead COVID drug Remdesivir should consider trial failure before showing green flag: WHO scientist Farhat Nasim25 Oct 2020 11:00 AM ISTGeneva: Health officials reviewing Gilead Science Inc's remdesivir against COVID-19 should consider all evidence, including a trial in which the...
Bharat Biotech gets DCGI nod to conduct phase 3 trial of Covaxin Ruchika Sharma24 Oct 2020 12:26 PM ISTA subject expert committee on Covid19 at the CDSCO had recommended granting permission to the Bharat Biotech for conducting phase 3 clinical trial of...
Dr Reddys suffers cyber-attack, temporarily shuts operations across globe Ruchika Sharma23 Oct 2020 5:45 PM ISTBengaluru: In an alarming incident, the Hyderabad-based drugmaker Dr Reddy's Laboratories recently suffered a cyber attack. The firm has now isolated...
